M 433 Pill - orange round, 11mm
Pill with imprint M 433 is Orange, Round and has been identified as Bupropion Hydrochloride 75 mg. It is supplied by Mylan Pharmaceuticals Inc.
Bupropion is used in the treatment of Major Depressive Disorder; Depression; Seasonal Affective Disorder; Smoking Cessation and belongs to the drug classes miscellaneous antidepressants, smoking cessation agents. Risk cannot be ruled out during pregnancy. Bupropion 75 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M 433
Bupropion Hydrochloride
- Imprint
- M 433
- Strength
- 75 mg
- Color
- Orange
- Size
- 11.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Miscellaneous antidepressants, Smoking cessation agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients
-
lactose anhydrous,
silicon dioxide,
hydrochloric acid,
microcrystalline cellulose,
polydextrose,
stearic acid,
titanium dioxide,
triacetin,
ferric oxide red,
ferric oxide yellow
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
00378-0433 (Discontinued) | Mylan Pharmaceuticals Inc. |
51079-0943 (Discontinued) | UDL Laboratories Inc. |
67544-0406 | Prepak Systems Inc. (repackager) |
Related images for "M 433"
More about bupropion
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (2,869)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: miscellaneous antidepressants
- Breastfeeding
Patient resources
- Bupropion drug information
- Bupropion Extended-Release Tablets
- Bupropion Sustained-Release Tablets (Smoking Deterrent)
- Bupropion Tablets and Sustained-Release Tablets
Other brands
Wellbutrin, Wellbutrin XL, Wellbutrin SR, Zyban, ... +5 more
Professional resources
Other brands
Wellbutrin, Wellbutrin XL, Wellbutrin SR, Zyban, ... +2 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.